Copyright Reports & Markets. All rights reserved.

Global and China Breakthrough Therapy (BT) Designation Market Research by Company, Type & Application 2013-2025

Buy now

Table of Content

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 Oncology
        • 1.1.2.2 Infectious Diseases
        • 1.1.2.3 Rare Diseases
        • 1.1.2.4 Autoimmune Diseases
        • 1.1.2.5 Pulmonary Diseases
        • 1.1.2.6 Neurological Disorders
        • 1.1.2.7 Others
      • 1.1.3 Market by Application
        • 1.1.3.1 Hospital
        • 1.1.3.2 Clinic
        • 1.1.3.3 Research Institute
        • 1.1.3.4 Laboratories
    • 1.2 Global and China Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and China Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and China Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and China Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 China Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Roche
      • 6.1.1 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Abbvie
    • 6.3 Novartis International AG
    • 6.4 Janssen
    • 6.5 BMS
    • 6.6 Eli Lilly
    • 6.7 Gilead
    • 6.8 Sanofi
    • 6.9 Regeneron
    • 6.10 Acadia
    • 6.11 Boehringer Ingelheim
    • 6.12 Amgen
    • 6.13 AstraZeneca
    • 6.14 GlaxoSmithKline
    • 6.15 Vertex
    • 6.16 Alexion
    • 6.17 Merck
    • 6.18 Jazz Pharmaceuticals
    • 6.19 Exelixis
    • 6.20 Eisai
    • 6.21 Takeda
    • 6.22 Pfizer

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary

    Market Segment as follows:
    By Type
    Oncology 
    Infectious Diseases 
    Rare Diseases 
    Autoimmune Diseases 
    Pulmonary Diseases 
    Neurological Disorders 
    Others
    By Application
    Hospital 
    Clinic 
    Research Institute 
    Laboratories
    By Company
    Roche 
    Abbvie 
    Novartis International AG 
    Janssen 
    BMS 
    Eli Lilly 
    Gilead 
    Sanofi 
    Regeneron 
    Acadia 
    Boehringer Ingelheim 
    Amgen 
    AstraZeneca 
    GlaxoSmithKline 
    Vertex 
    Alexion 
    Merck 
    Jazz Pharmaceuticals 
    Exelixis 
    Eisai 
    Takeda 
    Pfizer
    The main contents of the report including:
    Section 1:
    Product definition, type and application, global and China market overview;
    Section 2:
    Global and China Market competition by company;
    Section 3:
    Global and China sales revenue, volume and price by type;
    Section 4:
    Global and China sales revenue, volume and price by application;
    Section 5:
    China export and import;
    Section 6:
    Company information, business overview, sales data and product specifications;
    Section 7:
    Industry chain and raw materials;
    Section 8:
    SWOT and Porter's Five Forces;
    Section 9:
    Conclusion.

    Buy now